3-phosphoinositide-dependent protein kinase 1 mRNA (PDPK1 mRNA)

3-phosphoinositide-dependent protein kinase 1 (PDPK1) mRNA is the messenger RNA transcript that encodes the PDK1 protein, a central node in the phosphoinositide 3-kinase (PI3K) signaling pathway (NCBI Gene ID: 5170). As a master kinase, the protein product of this mRNA phosphorylates and activates at least 20 other AGC kinases, including AKT, p70S6K, and protein kinase C (PKC) isoforms, which are vital for regulating cell growth, proliferation, and apoptosis resistance (UniProt: P54646). In many human cancers, PDPK1 is overexpressed or hyperactivated, making its mRNA an attractive target for gene-silencing therapies such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs). By targeting the mRNA for degradation, these therapeutic agents can effectively reduce the total cellular concentration of the PDK1 protein, thereby dampening oncogenic signaling cascades (PubMed: 15601765). This strategy is particularly relevant in tumors that have developed resistance to traditional small-molecule kinase inhibitors (PubMed: 12124331). Clinical and preclinical studies, such as those involving the ASO ISIS 21059, have explored PDPK1 mRNA as a target to treat solid tumors and overcome pathway-driven drug resistance.

Other names

PDK1 mRNA3-phosphoinositide-dependent protein kinase 1 transcripthPDK1 mRNAPDPK1 transcriptPDK1-ASO target

Antisense oligonucleotide-mediated RNase H cleavage of mRNA or RNA interference (RNAi) resulting in the knockdown of PDPK1 protein expression (PubMed: 15601765).